Below is the current list of sessions and events for the 2020 BIO Investor Forum Digital. More sessions and events will be added in the lead up to the event, so check back regularly for updates. 

BIO Investor Forum Digital
Date
  • Show All
Time
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Sessions
BIO Investor Forum Digital
Jump to Day
22 Results
  • Show All
Tuesday, October 13
7:45 AM - 8:30 AM (PDT)
Join us for a fireside chat with BIO’s Leadership, Chairman Jeremy Levin, MB, BChir, DPhil,…
8:30 AM - 9:30 AM (PDT)
With the spread of a pandemic that disproportionately affects communities of color and continued…
9:30 AM - 10:00 AM (PDT)
Governments, the health care industry, and the media have all been sounding the alarm about the…
10:00 AM - 11:00 AM (PDT)
By 2035, it is estimated that 24 million cancer cases will occur on an annual basis. Although…
11:00 AM - 12:00 PM (PDT)
More than half of biotech CEOs are first-time CEOs, but even the most experienced leadership teams…
12:00 PM - 1:00 PM (PDT)
Hear from Kite Executives during this first of its kind Fireside Chat at the BIO Investor Forum.
1:00 PM - 2:00 PM (PDT)
As the furthest developed new Alzheimer’s therapy candidate approaches a regulatory review decision…
2:00 PM - 2:30 PM (PDT)
David Thomas, BIO’s Vice President of Industry Analysis, will provide an overview of recent…
2:30 PM - 3:00 PM (PDT)
On a record-setting pace, more than $5B dollars were investing in the first half of 2020 in digital…
3:00 PM - 4:00 PM (PDT)
Biomarker discovery and renewed attention on the regulatory front is ushering in a new era for…
4:00 PM - 5:00 PM (PDT)
Deloitte reports a cooling down effect in biopharma cross-border transactions in 2019 due political…
5:00 PM - 6:00 PM (PDT)
This dynamic session will feature James Antonopoulos of ROTH Capital Partners interviewing Nisa…
Wednesday, October 14
8:00 AM - 9:00 AM (PDT)
Join this session to learn about the rise in SPACs (special purpose acquisition companies) for…
9:00 AM - 10:00 AM (PDT)
The fast-approaching November U.S. elections may impact the biopharma industry particularly with…
10:00 AM - 11:00 AM (PDT)
A recent Nature Biotechnology article notes that less than 1% of the nearly 200 senior-level…
11:00 AM - 12:00 PM (PDT)
With more than 75% of clinical trials disrupted due to the COVID-19 pandemic, many biopharma…
12:00 PM - 1:00 PM (PDT)
Recent data shows venture investment in AI-focused biopharma companies appears to be accelerating…
2:00 PM - 3:00 PM (PDT)
In July, the U.S. economy suffered from a 32.9% contraction in GDP, the largest in recent history…
3:00 PM - 3:30 PM (PDT)
A “valley of death” in funding availability continues to endure between the academic researcher and…
3:30 PM - 4:00 PM (PDT)
Traditional efforts to optimize biomedical supply chains for quality and efficiencies of scale have…
4:00 PM - 5:00 PM (PDT)
With more than 20 million infections of COVID-19 across the globe and no approved treatments, the…